Readout Capital, LP
readoutcap.com Direct investor
Readout Capital is an investment firm focused on biotech, led by two co-founders with backgrounds in biotech investing and scientific research.
Readout Capital, LP is an asset manager. It invests directly in companies, in biotech.
- Layer
- Direct investor
- Type
- Asset manager
- Stage
- Not stated
- Sectors
- biotech
Team, as Readout Capital, LP publishes it
- Matthew Smith Co-Founder and Chief Investment Officer
- James Dahlman, PhD Co-Founder and Chief Scientific Officer
Names and roles exactly as listed on readoutcap.com. Nothing else about these people is recorded.
Where this comes from
Every fact above was read from a page Readout Capital, LP publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.
- https://readoutcap.com/sectors, people, type
Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.
Record 3990 · added 2026-09-03 · link last verified 2026-10-21 · confidence medium
Similar investors
- Acorn Capital LimitedAsset manager · Growth · Melbourne, Australia
- ACT Capital Management, LLCAsset manager · Wayne, United States
- Aescap Life SciencesAsset manager · Not applicable · Amsterdam, Netherlands
- AIP Investment Partners Pte. Ltd.Asset manager · Growth · Singapore, Singapore
- Ally Bridge GroupAsset manager · Growth · Hong Kong SAR China
- Altium Capital ManagementAsset manager · Seed – Growth · New York, United States